Perspectum awarded $250k FDA grant for rare disease research
The grant will support Perspectum’s research into the development of a novel biomarker for primary sclerosing cholangitis ...
Encision Reports Second Quarter Fiscal Year 2025 Results
BOULDER, CO / ACCESSWIRE / November 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant ...
Encision, Inc.: Encision Reports Second Quarter Fiscal Year 2025 Results
BOULDER, CO / ACCESSWIRE / November 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant ene ...